INBX

INHIBRX BIOSCIENCES INC

INBX·45720N103·US·Common Stock·Healthcare - Biotechnology-13D/G

INBX (INHIBRX BIOSCIENCES INC) is held by 96 institutional investors as of Q2 2026. Largest holders: MORGAN STANLEY ($123.9M), VIKING GLOBAL INVESTORS LP ($106.5M), HighTower Advisors, LLC ($82.5M). Net institutional sentiment: Mixed.

96
Holders
(6 Elite)
$943.5M
Total Value
64% (98)
Consensus
63 buying - 35 selling
13F: Insider & Congress: Updated regularly
INBX

Smart Money Verdict

View all
Loading verdict
Held by 96 funds
6 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Oct 9, 2025 · Activists Aug 14, 2026 · Congress none

ActivistSchonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC5.3%Aug 14, 2026
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP9.3%Aug 14, 2026
ActivistPAPerceptive Advisors LLC10.0%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.3M(+3.6%)$123.9M0.0%+97.64%
31
Decreased
1.1M(-21.8%)$106.5M0.3%+770.92%
0
Increased
870,551(+0.0%)$82.5M0.1%+725.28%
30
Increased
841,141(+2473.6%)$79.7M0.0%+31.92%
48
Increased
825,972(+3.4%)$78.3M0.0%+368.56%
31
Increased
697,586(+173.8%)$66.1M0.2%+55.05%
57
Increased
640,458(+16.3%)$60.7M0.0%+108.93%
34
Increased
492,477(+1.2%)$46.7M0.0%+65.47%
30
Increased
400,892(+4.3%)$38M0.1%+127.40%
36
Decreased
363,050(-7.6%)$34.4M0.0%+58.26%
0
Increased
338,176(+255.7%)$32M0.0%+43.18%
47
Increased
271,700(+59.2%)$25.7M0.0%+46.54%
41
Increased
256,175(+10.7%)$24.3M0.0%+405.06%
32
Decreased
147,200(-55.1%)$13.9M0.0%+396.70%
0
New
128,424$12.2M0.0%+30.25%
39
Increased
122,557(+69.1%)$11.6M0.0%+49.27%
41
Increased
100,957(+7.8%)$9.6M0.0%+425.72%
30
Increased
75,721(+21.1%)$7.2M0.0%+60.64%
33
Increased
73,416(+88.4%)$7M0.0%
43
Increased
69,920(+8.7%)$6.6M0.0%+62.46%
30

Showing 1-20 of 106

1 / 6
INBXINBXINHIBRX BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used